Home › Sakit sa Puso at Ugat ng Dugo › Florida › Orlando
Pag-aaral pangklinika para sa Sakit sa Puso at Ugat ng Dugo sa Orlando, FL
14 pag-aaral para sa Sakit sa Puso at Ugat ng Dugo ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Orlando (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Nagre-recruitPhase 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · 6 mi ang layo
- Omega Research Orlando, Altamonte Springs · 9 mi ang layo
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Nagre-recruitPhase 3
- Florida Institute for Clinical Research, Orlando
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Nagre-recruitPhase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi ang layo
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Nagre-recruitPhase 3
- Clinical Trial Site, Orlando
- Clinical Trial Site, Winter Park · 5 mi ang layo
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Nagre-recruitPhase 3
- Clinical Research Site, Kissimmee · 16 mi ang layo
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Nagre-recruit
- Advent Health, Orlando
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Nagre-recruitPhase 2
- Clinical Research Site, Kissimmee · 16 mi ang layo
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Nagre-recruitObservasyonal na pag-aaral
- Arnold Palmer Hospital for Children, Orlando
- Nemours Children's Hospital, Orlando
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Nagre-recruitPhase 3
- Research Site, Orlando
- Research Site, Orlando
- Research Site, Orlando
- at 2 pa
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Nagre-recruitPhase 3
- Clinical Site Partners Orlando dba Flourish Research, Winter Park · 5 mi ang layo
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Nagre-recruitPhase 3
- FC Site Partners Miami, Winter Park · 5 mi ang layo
SPYRAL GEMINI Pilot Study
Nagre-recruit
- Orlando Health Heart & Vascular Institute, Orlando
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Nagre-recruit
- Advent Health Hospital, Orlando
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Nagre-recruitPhase 3
- AdventHealth, Orlando
Pag-aaral para sa Sakit sa Puso at Ugat ng Dugo sa ibang lungsod
- Boston, MA37 pag-aaral
- New York City, NY33 pag-aaral
- Washington, DC29 pag-aaral
- Houston, TX24 pag-aaral
- Dallas, TX23 pag-aaral
- Atlanta, GA22 pag-aaral
- Cleveland, OH22 pag-aaral
- Chicago, IL21 pag-aaral
- Philadelphia, PA21 pag-aaral
- Pittsburgh, PA20 pag-aaral
- St. Louis, MO20 pag-aaral
- San Francisco, CA18 pag-aaral
Iba pang pag-aaral sa Orlando
- Non-Small Cell Lung Cancer44 pag-aaral
- Obesity31 pag-aaral
- Metastatic Cancer29 pag-aaral
- Overweight27 pag-aaral
- Sakit ni Alzheimer25 pag-aaral
- Type 2 Diabetes24 pag-aaral
- Kanser (lahat ng uri)24 pag-aaral
- Kanser sa Suso23 pag-aaral
- Kanser sa Ovary22 pag-aaral
- Ulcerative Colitis22 pag-aaral
- Kanser sa Baga21 pag-aaral
- Colorectal Cancer19 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.